Subscription Pricing for Telehealth Brands: Models That Retain

Most DTC telehealth brands should default to a monthly, program-based subscription that bundles provider access and (where pharmacy economics allow) the medication itself, then earn longer commitments with quarterly or annual prepay options rather than leading with them. À la carte pricing has its place in episodic care, but in recurring-therapy categories like GLP-1 weight loss, TRT, and hair loss, the subscription is not a billing convenience: it is the product. The model you pick determines your revenue predictability, your churn profile, and how much of your operational week gets eaten by billing exceptions.

The uncomfortable truth about telehealth subscription pricing is that retention is designed in, not discounted in. Deep intro offers, hidden cancellation flows, and sloppy dunning all buy short-term metrics at the cost of long-term ones, and regulators have made two of those three actively dangerous. This post walks through the main models and their tradeoffs, medication-inclusive versus medication-separate pricing, intro offers, cancellation and refund reality, involuntary churn, and what your billing infrastructure has to do to support it all.

Key takeaways

• The dominant telehealth subscription pricing models are monthly membership, quarterly or annual prepay, per-program medication-inclusive bundles, and à la carte visits plus medication, and each trades revenue predictability against churn risk and operational complexity differently.
• Medication-inclusive pricing simplifies the patient's decision and stabilizes perceived value, but it moves medication cost risk onto the brand, so pharmacy economics should drive the choice.
• Discounted intro offers reliably inflate month-one signups and just as reliably create a renewal cliff, because they attract price-driven buyers and reset the price anchor below your real rate.
• Cancellation friction is now a regulatory issue, not just a retention tactic: negative-option and auto-renewal rules increasingly require cancellation to be as easy as signup.
• Involuntary churn from failed payments is one of the most fixable revenue leaks in subscription telehealth, and it is solved with dunning mechanics, not marketing.

What are the main telehealth subscription pricing models?

Four models cover almost every DTC telehealth brand in market.

1. Monthly membership. A flat recurring fee covering provider access, messaging, and program support, billed every month, cancellable anytime, with medication included or billed separately. This is the default for recurring-therapy verticals because it matches how patients think about ongoing treatment and keeps the signup decision small.

2. Quarterly or annual prepay. The same program, paid for three or twelve months upfront, usually at an effective discount. Prepay pulls cash forward, filters for committed patients, and removes monthly renewal decisions. The costs: a bigger upfront ask that suppresses conversion, larger refund exposure when someone quits mid-term, and a concentrated renewal event where the deferred churn shows up at once.

3. Per-program bundles. A packaged program with a defined scope, priced as one recurring number. The canonical example is the GLP-1 monthly plan that includes the provider consult, ongoing clinical oversight, the medication shipment, and support in a single price. Bundles are the strongest retention structure in the recurring verticals because the patient is subscribed to a treatment outcome, not a membership card. They are also the most operationally demanding, since billing, clinical review, and fulfillment must stay synchronized every cycle. If you are building in this category, our guide to launching a GLP-1 weight-loss brand covers the program design side in depth.

4. À la carte visits plus medication. Pay per consult; pay per fill. No commitment, lowest friction, and a sensible fit for episodic care or as an entry rung under a subscription. As a primary model for recurring therapy it is weak: every refill becomes a repurchase decision, and you rebuy your own customer every month.

Most mature brands run a hybrid: a bundle as the flagship, a prepay option for the committed, and an à la carte entry point that feeds the subscription. Whether visits are asynchronous or synchronous also shapes what you can bundle and at what cadence, which we break down in async vs sync telehealth.

Should the medication be included in the subscription price?

This is the biggest structural decision in telehealth subscription pricing, and pharmacy economics should drive it, not marketing preference.

Medication-inclusive pricing means one number covers care and medication. Patients strongly prefer it: no surprise pharmacy bill, no per-fill decision, no monthly comparison shopping against every other brand selling the same molecule. It converts and retains better because the value is concrete: the medication arrives, therefore the subscription is working. The cost is that you have taken on medication COGS risk. If medication cost moves (a compounding rule changes, a supplier reprices, a patient titrates to a higher dose), your margin absorbs it. Inclusive pricing works when your pharmacy relationships give you stable per-fill costs and dose progression is either bounded or priced into tiers.

Medication-separate pricing keeps the subscription as a care-and-access fee, with medication billed at cost or with a stated margin per fill. It protects the brand from medication cost volatility and keeps the headline price low. The tradeoffs: total cost of ownership is harder for the patient to evaluate, the checkout has more steps, and every fill is a moment where the patient re-evaluates. It also invites comparison on medication price alone, which is exactly the commoditized fight a brand exists to avoid.

A practical middle path in dose-variable categories like GLP-1s is tiered inclusive pricing: one bundle price per dose tier, so titration moves patients between published tiers instead of generating surprise invoices or eroding your margin.

Whichever way you go, interrogate your infrastructure partner's medication economics before you set prices. A platform that makes its real margin on medication markup constrains you differently than one with pass-through pricing, a point we also flag in our cost to start a telehealth business breakdown.

Do intro offers help or hurt retention?

They help acquisition and hurt retention, and the second effect outlasts the first. Three mechanisms drive the hangover:

• Selection. A steep first-month discount recruits price-driven buyers into a product whose economics depend on multi-month persistence. The patients most responsive to the offer are, by construction, the most likely to leave when the price normalizes.
• Anchoring. The intro price becomes the reference price. The step up to full rate is experienced as a price increase, and it lands at exactly the moment early side effects or unmet expectations are also peaking in verticals like GLP-1.
• Payback stretch. Discounting month one pushes your acquisition payback later, so any churn at the renewal cliff hurts more than the same churn would in an undiscounted cohort.

None of this means never discount. It means discount where the hangover is smallest: on à la carte entry offers that feed the subscription, on later cycles as a retention save rather than the first as bait, or as extra value instead of a lower price. A brand whose intro economics only work if the patient forgets to cancel has built a churn machine with a delay timer.

How much cancellation friction is too much?

Less than most founders think, and the constraint is now regulatory as much as reputational. The FTC has pushed hard on negative-option and "click-to-cancel" rules, and a growing set of state auto-renewal laws add their own requirements: clear disclosure of renewal terms before purchase, affirmative consent, renewal reminders in some states, and cancellation roughly as simple as signup. Card networks layer on their own subscription-billing rules. The era of cancel-by-phone-only telehealth subscriptions is ending, and brands that cling to it collect chargebacks, complaints, and platform risk a subscription health business cannot afford. This is general information, not legal advice; have counsel review your subscription terms and cancellation flow against the current rules in your states.

There is also a telehealth-specific wrinkle: a cancellation is sometimes a clinical event. A patient mid-titration may need provider outreach about discontinuation; a prepaid patient cancelling after a medication has shipped raises refund questions pure-software subscriptions never face. Sensible practice: a clean self-serve cancellation flow with a well-designed offramp (pause, downgrade, switch to à la carte) and a published refund policy that distinguishes services rendered and medication dispensed from unused prepaid time. Retention tactics belong before the cancellation page and on it as genuinely useful alternatives, never behind it as a maze.

What is involuntary churn, and how does dunning fix it?

A meaningful slice of subscription cancellations are not decisions at all. Cards expire, get reissued after fraud, or bounce for insufficient funds, and the subscription dies by accident. This is involuntary churn, and it is uniquely painful in telehealth: a billing failure interrupts therapy, which then damages the outcome that was driving retention in the first place.

Dunning is the machinery that fights it, and it is mechanical rather than creative:

• Smart retries. Failed charges are retried on a schedule informed by failure codes; a soft decline and a dead card deserve different handling.
• Account-updater services. Card networks can push refreshed card numbers to merchants automatically, rescuing subscriptions that would otherwise fail on expiry.
• Pre-billing and pre-expiry notices. Reminders before renewal and card expiration convert silent failures into easy fixes, and double as compliance hygiene where renewal notices are required.
• Grace periods with clinical guardrails. A short window where the account stays active while payment recovers, with one hard rule: medication does not ship against a failed payment.
• Pause instead of terminate. When recovery fails, a paused account with an easy restart preserves the relationship a hard cancellation destroys.

Brands that treat dunning as a plumbing detail leak revenue every month to failures no one decided. Brands that treat it as a retention channel recover a real share of those failures with software alone.

How does billing infrastructure support these models?

Every model above is easy to draw on a whiteboard and hard to run when billing, clinical care, and pharmacy fulfillment live in separate systems. The recurring failure pattern is state drift: the card was charged but the refill was never clinically reviewed, the medication shipped after the payment failed, or the patient cancelled and the pharmacy shipped anyway.

This is the problem OrbitOS subscription billing is built around. Because OrbitOS is the same multi-tenant console that manages patients, encounters, and prescriptions, subscription state is connected to clinical and fulfillment state rather than bolted on beside them. The mechanics this post describes are supported as workflows, not custom code: monthly, prepay, and medication-inclusive bundle structures; plan switching and pauses as retention offramps; refill holds when a payment fails or a provider review is pending; and dunning that talks to fulfillment instead of past it. The clinical layer underneath is MyOrbitHealth's network of 1,240+ board-certified providers across 38+ specialties in all 50 states, averaging sub-six-minute responses during business hours, which matters because slow provider responses are a quiet churn driver no pricing model can compensate for.

Platform economics frame the pricing decision too: your subscription price has to clear fixed infrastructure costs at a realistic member count. For a public category benchmark, Telegra publishes two-tier platform pricing of $3,000 per month (Plus) and $6,000 per month (Pro) as of mid-2026, with consult fees billed separately; most other platforms gate pricing behind a demo. How the whole model fits together, including where billing sits in the stack, is covered in our white-label telehealth platform guide.

Frequently asked questions

What is the most common pricing model for DTC telehealth brands?

Monthly subscriptions dominate, and in medication-led verticals like GLP-1 weight loss and TRT the strongest version is a per-program bundle where one recurring price covers provider access, oversight, and often the medication. Quarterly and annual prepay typically exist as options layered on top of a monthly flagship rather than as the lead offer.

Should a telehealth subscription include the medication in the price?

Include it when your pharmacy economics are stable and predictable, because patients convert and retain better on a single all-in price. Keep it separate when medication costs are volatile or dose-dependent in ways you cannot price, or use dose-based tiers as a middle path. The deciding factor is who can better absorb medication cost risk, you or the patient.

Are discounted intro offers a bad idea for telehealth subscriptions?

Deep first-month discounts are usually a trap: they attract price-driven buyers, anchor expectations below your real price, and create a churn cliff at the first full-price renewal. Discounts work better as retention saves in later cycles, as à la carte entry offers that feed the subscription, or as added value instead of a lower price.

Is it legal to make a telehealth subscription hard to cancel?

Increasingly, no. FTC negative-option rules and state auto-renewal laws push toward cancellation being roughly as easy as signup, with clear renewal disclosures and, in some states, renewal reminders. Beyond legality, cancellation friction in healthcare generates chargebacks and complaints that threaten payment processing and ad accounts. This is general information, not legal advice.

What is involuntary churn in subscription telehealth?

Involuntary churn is subscription loss from payment failure rather than patient choice: expired cards, reissued numbers, and declined charges. It is addressed with dunning mechanics such as smart retries, card account updaters, pre-billing notices, and grace periods, with the telehealth-specific rule that medication never ships against a failed payment.

How does MyOrbitHealth handle subscription billing?

OrbitOS includes subscription billing connected to the clinical and fulfillment layers, so plan structures like monthly memberships, prepay terms, and medication-inclusive bundles stay synchronized with provider review and pharmacy shipment. Billing state changes, such as a failed payment or a pause, automatically flow through to refill and fulfillment decisions.

Price for retention, then let the infrastructure carry it

The right subscription model is the one your operations can keep in sync: billing, clinical review, and pharmacy shipment moving as one system. MyOrbitHealth runs that system behind founder-owned brands, from OrbitOS subscription billing to a 50-state provider network with sub-six-minute average response during business hours. Bring your vertical and pricing ideas, and we will pressure-test the model with you. Book a demo with MyOrbitHealth.